Creative Planning
PLSE icon

Creative Planning’s Pulse Biosciences PLSE Stock Holding History

Creative Planning’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Buy
21,040
+4,627
+28% +$109K ﹤0.01% 3079
2026
Q1 		$354K Sell
16,413
-826
-5% -$15.2K ﹤0.01% 3288
2025
Q4 		$237K Sell
17,239
-2,068
-11% -$32.2K ﹤0.01% 3419
2025
Q3 		$342K Buy
19,307
+336
+2% +$5.32K ﹤0.01% 3040
2025
Q2 		$286K Buy
18,971
+3,951
+26% +$65.6K ﹤0.01% 2935
2025
Q1 		$242K Sell
15,020
-1,010
-6% -$18.8K ﹤0.01% 2920
2024
Q4 		$279K Sell
16,030
-5,880
-27% -$104K ﹤0.01% 2723
2024
Q3 		$384K Buy
21,910
+11,667
+114% +$199K ﹤0.01% 2330
2024
Q2 		$115K Buy
+10,243
New +$96.5K ﹤0.01% 2814
2017
Q3 		– Sell
-300
Closed -$10K – 3218
2017
Q2 		$10K Sell
300
-175
-37% -$4.81K ﹤0.01% 3630
2017
Q1 		$10K Buy
+475
New +$6.47K ﹤0.01% 3600

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Creative Planning's PLSE Position: Q2 2026 in Review

Creative Planning increased its Pulse Biosciences (PLSE) stake by 28% in Q2 2026, buying an estimated $109K and bringing the position to 21,040 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Creative Planning first reported a position in PLSE in Q1 2017 and has held it in 11 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Creative Planning held 21,040 shares of Pulse Biosciences worth $583K as of Q2 2026.
  • Creative Planning bought 4,627 Pulse Biosciences shares in Q2 2026, an estimated $109K.
  • Pulse Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3079 holding.
  • Creative Planning first reported a position in Pulse Biosciences in Q1 2017 and has held it in 11 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.